Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $161.76 in the prior trading day, Natera Inc (NASDAQ: NTRA) closed at $158.69, down -1.90%. In other words, the price has decreased by -$1.90 from its previous closing price. On the day, 0.75 million shares were traded. NTRA stock price reached its highest trading level at $161.435 during the session, while it also had its lowest trading level at $158.68.
Ratios:
Our goal is to gain a better understanding of NTRA by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 21.85 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 254.36. For the most recent quarter (mrq), Quick Ratio is recorded 3.74 and its Current Ratio is at 3.87. In the meantime, Its Debt-to-Equity ratio is 0.16 whereas as Long-Term Debt/Eq ratio is at 0.08.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, RBC Capital Mkts on March 13, 2025, initiated with a Outperform rating and assigned the stock a target price of $251.
On January 23, 2025, Barclays started tracking the stock assigning a Overweight rating and target price of $200.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jul 02 ’25 when Sheena Jonathan sold 3,000 shares for $160.10 per share. The transaction valued at 480,309 led to the insider holds 35,782 shares of the business.
Chapman Steven Leonard sold 5,343 shares of NTRA for $889,778 on Jul 01 ’25. The CEO AND PRESIDENT now owns 173,728 shares after completing the transaction at $166.53 per share. On Jul 01 ’25, another insider, Moshkevich Solomon, who serves as the PRESIDENT, CLINICALDIAGNOSTICS of the company, sold 3,000 shares for $166.77 each. As a result, the insider received 500,305 and left with 130,205 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NTRA now has a Market Capitalization of 21668644864 and an Enterprise Value of 22272180224. For the stock, the TTM Price-to-Sale (P/S) ratio is 11.83 while its Price-to-Book (P/B) ratio in mrq is 17.40. Its current Enterprise Value per Revenue stands at 12.164 whereas that against EBITDA is -112.762.
Stock Price History:
The Beta on a monthly basis for NTRA is 1.78, which has changed by 0.45015073 over the last 52 weeks, in comparison to a change of 0.11708844 over the same period for the S&P500. Over the past 52 weeks, NTRA has reached a high of $183.00, while it has fallen to a 52-week low of $92.14. The 50-Day Moving Average of the stock is -0.82%, while the 200-Day Moving Average is calculated to be 3.96%.
Shares Statistics:
The stock has traded on average 1.34M shares per day over the past 3-months and 1342840 shares per day over the last 10 days, according to various share statistics. A total of 135.93M shares are outstanding, with a floating share count of 129.36M. Insiders hold about 5.26% of the company’s shares, while institutions hold 94.07% stake in the company. Shares short for NTRA as of 1749772800 were 6238549 with a Short Ratio of 4.64, compared to 1747267200 on 5908383. Therefore, it implies a Short% of Shares Outstanding of 6238549 and a Short% of Float of 4.77.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Natera Inc (NTRA) is currently under the scrutiny of 13.0 analysts, each contributing to the ongoing evaluation of its stock.The consensus estimate for the next quarter is -$0.57, with high estimates of -$0.41 and low estimates of -$0.69.
Analysts are recommending an EPS of between -$1.51 and -$2.8 for the fiscal current year, implying an average EPS of -$2.22. EPS for the following year is -$1.14, with 14.0 analysts recommending between $0.38 and -$2.58.
Revenue Estimates
16 analysts predict $476.46M in revenue for the current quarter. It ranges from a high estimate of $495.8M to a low estimate of $464M. As of the current estimate, Natera Inc’s year-ago sales were $413.35MFor the next quarter, 16 analysts are estimating revenue of $500.22M. There is a high estimate of $510M for the next quarter, whereas the lowest estimate is $490.8M.
A total of 19 analysts have provided revenue estimates for NTRA’s current fiscal year. The highest revenue estimate was $2.02B, while the lowest revenue estimate was $1.6B, resulting in an average revenue estimate of $1.97B. In the same quarter a year ago, actual revenue was $1.7BBased on 19 analysts’ estimates, the company’s revenue will be $2.29B in the next fiscal year. The high estimate is $2.47B and the low estimate is $1.86B.
